Now available: EpiPlex Uni-, Duo-, and Tri-Mod Services. Profile m6A, inosine, and pseudouridine alongside gene expression.

The EpiPlex™ Platform for Multi-Target Detection of RNA Modifications

Dr. Gudrun Stengel, CEO and co-founder of Alida Biosciences, introduces the role of RNA modifications in gene regulation and their emerging importance across biology. She also presents the EpiPlex™ Platform—a novel technology that combines engineered molecular recognition and proximity barcoding for transcriptome-wide, multi-target detection and quantification of RNA modifications.